Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes
Related Experiment Video
Updated: Aug 14, 2026

Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
Published on: January 19, 2020
1Aarhus Kommunehospital, Aarhus University, Aarhus C, DK-8000, Denmark. perlogstrup@mail.dk
Insights
Diabetic nephropathy affects 25-30% of Type 1 diabetes patients. Early detection via microalbuminuria and managing blood pressure are key to preserving kidney function and reducing mortality.
Area of Science:
- Nephrology
- Endocrinology
- Cardiology
Background:
- Diabetic nephropathy impacts 25-30% of Type 1 diabetes mellitus (T1DM) patients.
- Elevated blood pressure (BP) accelerates progression to end-stage renal failure.
- Microalbuminuria serves as an early marker for identifying at-risk T1DM patients.
Purpose of the Study:
- To review early renal changes in T1DM.
- To explore associations between urinary albumin excretion and various risk factors.
- To examine differences across normoalbuminuria, progressing, and microalbuminuria groups.
Main Methods:
- Literature review focusing on early renal involvement in T1DM.
- Analysis of associations between urinary albumin excretion, glycemic control, smoking, BP, and autonomic function.
- Comparison of patient groups based on albuminuria levels.
Main Results:
- Microalbuminuric T1DM patients exhibit characteristic abnormalities including elevated BP, abnormal circadian rhythms, and impaired vagal function.
- Associated factors include dyslipidemia, endothelial dysfunction, and increased retinopathy prevalence.
- The review examines links between albuminuria and BP, glycemic control, smoking, and autonomic dysfunction.
Conclusions:
- Early identification of microalbuminuria is crucial for intervention in T1DM.
- Multiple factors, including BP and autonomic function, contribute to diabetic nephropathy progression.
- Understanding these early changes aids in preserving glomerular filtration rate and reducing mortality.
Abstract:
The cumulative incidence of diabetic nephropathy in Type 1 diabetes mellitus is in the order of 25 30%. The recognition that elevated blood pressure (BP) is a major factor in the progression of these patients to end-stage renal failure has led to the widespread use of antihypertensive therapy in order to preserve glomerular filtration rate and ultimately to reduce mortality. The routine measurement of microalbuminuria allows early identification of the subgroup of patients at increased risk of developing clinical nephropathy. Microalbuminuric Type 1 diabetic patients show a number of characteristic pathological abnormalities. In addition to elevated BP and abnormal circadian rhythm, there are also associated abnormalities of vagal function, lipid profile and endothelial function, as well as an increased prevalence of retinopathy. The first section of this two-part review focusses on the early changes associated with renal involvement in Type 1 diabetes. It addresses the associations between urinary albumin excretion, glycaemic control, smoking, BP, circadian BP variation, QT interval abnormalities and autonomic function in three groups of patients; those with normoalbuminuria, those progressing towards microalbuminuria and those with established low-grade microalbuminuria.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypertension and Regulation of Blood Pressure
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease I: Introduction
Type II Diabetes II: Pathophysiology

